Sun Dec 14 06:07:53 UTC 2025: Okay, here’s a summary and news article based on the provided information:

Summary:

Novo Nordisk India’s Managing Director, Vikrant Shrotriya, has announced that the launch of injectable semaglutide represents a major advancement in diabetes treatment.

News Article:

Novo Nordisk India Launches Injectable Semaglutide, Heralding New Era in Diabetes Care

New Delhi, India – Novo Nordisk India has launched injectable semaglutide, a move hailed as a significant breakthrough in diabetes management. In an exclusive interview with NDTV, Managing Director Vikrant Shrotriya emphasized the importance of this launch, stating that it marks a crucial step forward in the treatment of diabetes. The company anticipates that injectable semaglutide will offer improved therapeutic options for patients struggling to manage their condition. Further details about the drug’s availability and pricing are expected to be released shortly.

Read More